Snapshot

DOI:

A State-of-the-Art on antithrombotic therapy in complex PCI; optimal minimal stent areas after left main crossover stenting; VARC-HBR criteria validation for TAVI; the balloon-expandable DurAVR transcatheter heart valve; valve-in-valve TAVI and redo-TAVI; and more...

State-of-the-art on antithrombotic therapy in complex PCI

Covering the current state of antithrombotic therapies in complex percutaneous coronary intervention (PCI), Domenico Simone Castiello, Raffaele Piccolo and colleagues provide us with a state-of-the-art examining different types and durations of antithrombotic strategies. They also review management within specific settings, including patients with long-term indications for oral anticoagulation.

Optimal minimal stent area after left main crossover stenting

Ju Hyeon Kim, Seung-Jung Park and colleagues analyse intravascular ultrasound-derived minimal stent area criteria for optimal stent expansion following left main crossover stenting. Using the 5-year major adverse cardiac events data available from their centre, the authors established three threshold values to serve as benchmarks for stent optimisation during left main PCI. José M. de la Torre Hernandez comments in an accompanying editorial.

VARC-HBR criteria for risk stratification and prediction of bleeding risk in TAVI

In a subanalysis of the POPular PAUSE TAVI trial, Daniël C. Overduin, Jurrien M. ten Berg and colleagues evaluate the Valve Academic Research Consortium High Bleeding Risk (VARC-HBR) criteria for risk stratification and prediction of bleeding risk in transcatheter aortic valve implantation (TAVI) patients and then compare it to other bleeding risk criteria. The authors find that use of the VARC-HBR criteria in clinical practice may help identify patient subgroups who would benefit from additional measures for access site management. This article is accompanied by an editorial from Kentaro Hayashida and Juri Iwata.

The new intra-annular balloon-expandable DurAVR valve

In this translational research bench study, David Meier, Stephanie L. Sellers and colleagues assess the hydrodynamic performance of the intra-annular balloon-expandable DurAVR transcatheter heart valve (THV) in native, valve-in-valve (ViV), and redo-TAVI procedures against other commercially available THVs. The valve demonstrated excellent hydrodynamics in all three scenarios, with minimal pinwheeling, especially in the ViV and redo-TAVI simulations.

For our last issue of the summer, we’ll end the season in the best EuroIntervention style with a wide range of articles to capture your interest and help keep you up to date on the latest research and trends...

Redo-TAVI with a supra-annular self-expanding THV for short-frame THVs

Giuseppe Tarantini, Luca Nai Fovino and colleagues offer practical guidance for performing redo-TAVI with a supra-annular THV in failing short-frame THVs. In this research correspondence, the authors examine the specific preprocedural and procedural considerations needed to optimise outcomes.

Volume 21 Number 18
Sep 15, 2025
Volume 21 Number 18
View full issue

Suggested by Cory
Trending articles
87.2

State-of-the-Art

10.4244/EIJ-D-25-00266 Jan 19, 2026
Lesion stratification with intracoronary imaging
McGarvey M et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
34.8

Original Research

10.4244/EIJ-D-25-01006 Mar 16, 2026
Clinical outcomes and haemodynamic response after blinded stress assessment of moderate aortic stenosis
Eerdekens R et al
22.2

Viewpoint

10.4244/EIJ-D-25-01066 May 4, 2026
Intracoronary imaging guidance for de novo coronary lesion treatment with drug-coated balloons
Amabile N et al
free
20.75

Flashlight

10.4244/EIJ-D-25-01014 Apr 6, 2026
Stent retriever-assisted coronary thrombectomy with continuous aspiration
Liabot Q et al
open access
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
17.8

Expert Review

10.4244/EIJ-D-25-01316 Apr 20, 2026
Electrosurgical laceration and stabilisation of tricuspid edge-to-edge repair: the ELASTA-T technique
Alvarez-Covarrubias H et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved